WCPO: After 35 years of surviving HIV and AIDS, Carl Fox is part of a study he believes will find a cure
Fox is part of UC's Trailblazer study
Carl Fox of Northern Kentucky found out he was HIV positive in 1985. After decades of living with the virus and watching the deaths of hundreds of friends, he joined a federally funded study and is allowing WCPO-TV to tell his story.
Carl Fichtenbaum, MD, of the UC Division of Infectious Diseases. Photo/Colleen Kelley/UC Creative + Brand
The TRAILBLAZER study, as it’s called, aims to change the parts of a patient’s white blood cells that HIV latches onto, says Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine.
Fichtenbaum is a principal investigator on the study and has been Fox’s doctor for years.
“The idea behind this study that we’re doing is to take a person’s cells from their white blood cells that harbor that receptor, take it in the laboratory, remove the receptor through genetic engineering and then infuse those cells back into the person,” he tells WCPO.
“Our hope in the future is that perhaps if we were to do this often enough, and change enough cells in the body, that people who have HIV may be able to control the HIV, even without any medication,” Fichtenbaum says. “And it may be the first steps or ideas to really trying to cure people.”
See the full WCPO study here and read more about the TRAILBLAZER study here.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
College of Medicine celebrates 100% match rate for Class of 2026
March 23, 2026
From local hospitals to the Mayo Clinic, the UC College of Medicine Class of 2026 achieved a 100% match rate for their residency training destinations.
Struggling with daily HIV meds?
March 23, 2026
For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.
Extended-release buprenorphine viable, safe during pregnancy
March 23, 2026
MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.